Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P77
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q3 2025 | 27.55% |
| Q2 2025 | 26.68% |
| Q1 2025 | 6.99% |
| Q4 2024 | 38.32% |
| Q3 2024 | -38.50% |
| Q2 2024 | 18.00% |
| Q1 2024 | -33.26% |
| Q4 2023 | -26.26% |
| Q3 2023 | 51.80% |
| Q2 2023 | -76.24% |
| Q1 2023 | 35.66% |
| Q4 2022 | 45.32% |
| Q3 2022 | -140.87% |
| Q2 2022 | 4.76% |
| Q1 2022 | -33.45% |
| Q4 2021 | 45.81% |
| Q3 2021 | -104.89% |
| Q2 2021 | -47.02% |
| Q1 2021 | 24.64% |
| Q4 2020 | 22.66% |
| Q3 2020 | -32.36% |
| Q2 2020 | -2.02% |
| Q1 2020 | -85.30% |
| Q4 2019 | 14.39% |
| Q3 2019 | -39.34% |
| Q2 2019 | -151.78% |
| Q1 2019 | 200.40% |
| Q4 2018 | 7.97% |
| Q3 2018 | -3.06% |
| Q2 2018 | -0.48% |
| Q1 2018 | -35.26% |
| Q4 2017 | 29.55% |
| Q3 2017 | -100.18% |
| Q2 2017 | 47.63% |
| Q1 2017 | 9.47% |
| Q4 2016 | 27.10% |
| Q3 2016 | 39.06% |
| Q2 2016 | -27.68% |
| Q1 2016 | -28.40% |
| Q4 2015 | 6.62% |